Send to

Choose Destination
J Pharm Pharmacol. 1999 Mar;51(3):295-300.

Ca2+/calmodulin-dependent protein kinase II inhibitors potentiate superoxide production in polymorphonuclear leukocytes.

Author information

Department of Pharmaco-Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Japan.


The possible role of Ca2+/calmodulin-dependent protein kinase II (CaMK II) in superoxide anion (O2-) production induced by formyl-methionyl-leucyl-phenylalanine (FMLP) was investigated in mouse polymorphonuclear leukocytes (PMNs). KN-93 and KN-62, specific CaMK II inhibitors, augmented FMLP-induced O2- production. KN-92, an analogue which did not inhibit CaMK II, did not affect O2- production. W-7, a calmodulin inhibitor, augmented O2- production when administered at 30 mM for 5 min. KN-93 and recombinant mouse tumour necrosis factor-alpha (rmTNF-alpha) each augmented the maximal production of O2- induced by FMLP, and an additive effect of a combination of KN-93 and rmTNF-alpha was observed. CaMK II activity in the PMNs was increased by FMLP, and the increase was inhibited by KN-93 but not by rmTNF-alpha. These results suggest that the inhibition of CaMK II resulted in the augmentation of FMLP-induced O2- production in PMNs by a mechanism different from that of the augmentation shown by TNF-alpha.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center